Name: Alto Neuroscience (ANRO) CEO On IPO & Treating Mental Health
Uploaded: 2024-02-02T23:00:32.659-06:00
Duration: 7 min 37 s
Description: Alto Neuroscience (ANRO) went public on the NYSE today. CEO Amit Etkin joins Nicole Petallides to give an overview of the company. Alto Neuroscience is a clinical-stage biopharmaceutical company that develops treatments for mental health. Tune in to find out more about the stock market today.

Morning Movers

Opening Bell With Nicole Petallides

Morning Trade Live

Trading 360

Fast Market

Next Gen Investing

The Watch List

Market On Close

Market Overtime

Inside the Mind of a Trader

Your First Trade

The Wrap

Liz Ann Live

Schwab 2026 Outlook

<p>The Watch List with Nicole Petallides offers investors a midday look at the most relevant stocks, sectors and commodities. Petallides hosts a panel of experts ranging from industry-leading CEOs, analysts and Wall Street influencers to discuss pressing topics moving the market in real-time. The Watch List provides viewers with a midpoint status update for the end of the trading day and beyond.</p>

Daily insights for every investor

Schwab Network's Newsletters

<p>Alto Neuroscience (ANRO) went public on the NYSE today. CEO Amit Etkin joins Nicole Petallides to give an overview of the company. Alto Neuroscience is a clinical-stage biopharmaceutical company that develops treatments for mental health. Tune in to find out more about the stock market today.</p>

Alto Neuroscience (ANRO) CEO On IPO & Treating Mental Health

Expert commentary about top moving stocks, sectors, and commodities, along with CEO and analyst interviews.

Market News